Yidong Liu
- Nephrology top 2%
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism 7
-
- Galectins and Cancer Biology 6
-
- Microbial Metabolic Engineering and Bioproduction 9
- Enzyme Catalysis and Immobilization 7
- Glycosylation and Glycoproteins Research 4
- Renal and related cancers 4
-
- Renal cell carcinoma treatment 9
-
- Amino Acid Enzymes and Metabolism 7
Yidong Liu
54 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 100
- Nephrology 248
- Critical Care and Intensive Care Medicine 62
- Cancer Research 180
- Immunology 192
- Molecular Biology 581
Countries citing papers authored by Yidong Liu
This map shows the geographic impact of Yidong Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yidong Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yidong Liu more than expected).
Fields of papers citing papers by Yidong Liu
This network shows the impact of papers produced by Yidong Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yidong Liu. The network helps show where Yidong Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yidong Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 2 | |
| 9 | 2022 | 1 | |
| 10 | 2022 | 2 | |
| 11 | 2021 | 25 | |
| 12 | 2015 | 20 | |
| 13 | 2015 | 9 | |
| 14 | 2015 | 17 | |
| 15 | 2015 | 11 | |
| 16 | 2015 | 102 | |
| 17 | 2014 | 15 | |
| 18 | 2013 | 23 | |
| 19 | 2013 | 38 | |
| 20 | 2008 | 24 |
About Yidong Liu
Yidong Liu is a scholar working on Biochemistry, Cancer Research and Nephrology, having authored 58 papers that have together received 1.2k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (9 papers), Microbial Metabolic Engineering and Bioproduction (9 papers), Amino Acid Enzymes and Metabolism (7 papers), Enzyme Catalysis and Immobilization (7 papers), Cancer, Hypoxia, and Metabolism (7 papers), Galectins and Cancer Biology (6 papers), Glycosylation and Glycoproteins Research (4 papers) and Renal and related cancers (4 papers). The work is most often cited by research in Nephrology (248 citations), Critical Care and Intensive Care Medicine (62 citations) and Cancer Research (180 citations). Yidong Liu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Jiejie Xu, Weisi Liu, Weijuan Zhang, Haiou Liu, Lodewijk V. Dekker, Gangli Gong, Le Xu, Donald W. Landry, Mélanie Viltard and Kai M. Schmidt‐Ott. Their work appears in journals such as Journal of Biological Chemistry, Nature Medicine and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.